Artivion | CRY - أصول متداولة





أصول متداولة تغيير تاريخ
Abbott USD 25.51B 488M 2026-03
Accuray USD 292.39M 11.22M 2025-12
AngioDynamics USD 161.35M 4.69M 2025-09
Artivion USD 371.38M 13.86M 2026-06
AtriCure USD 345.53M 31.84M 2026-06
Baxter International USD 6.99B 142M 2026-06
Becton, Dickinson and Co. USD 8.14B 127M 2026-06
Boston Scientific USD 7.97B 712M 2026-06
Edwards Lifesciences USD 6.82B 590.2M 2026-06
Inogen USD 203.72M 594K 2025-09
Integra LifeSciences USD 1.19B 19.46M 2026-06
J&J USD 59.77B 601M 2026-06
Mesa Laboratories USD 105.63M 8.2M 2025-12
Orthofix International USD 446.13M 15.39M 2026-06
Pfizer USD 41.36B 1.46B 2026-06
ResMed USD 4.32B 260.68M 2026-06
Stryker USD 14.42B 1.08B 2026-06
Tandem Diabetes Care USD 804.64M 82.46M 2026-06
Teleflex USD 1.88B 16.21M 2026-06
Terumo JPY 906.6B 45.57B 2026-06
Trinity Biotech USD 35.9M 382K 2025-12